Oncology Small Molecule Drugs Market is estimated to register a CAGR of ~6% through 2029 | Novartis Ag, Astrazeneca, Genentech, Pfizer
According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass US$ ~66 Bn in 2019, up from revenues [read full press release…]